Risperdal Class Action FAQs | Audet & Partners, LLP

Risperdal Class Action FAQs

Audet and Partners, LLP is now representing several males who have been diagnosed with Gynecomastia after having taken the antipsychotic drug Risperdal.  If you have suffered this or a similar injury, you may be wondering whether you may have a valid claim for damages.

The FAQs below are intended to better help you understand and assess how you might proceed in bringing a Risperdal lawsuit.

(1) What is the basis for the current Risperdal lawsuits against Johnson & Johnson?

For over a decade, Risperdal has been strongly linked in many studies to a condition known as Gynecomastia.  Gynecomastia results in abnormal growth of breast tissue in males.

(2) How is it believed that Risperdal causes Gynecomastia?

It is believed that Risperdal causes elevated levels of a hormone called prolactin. Prolactin is known to be a chemical precursor to breast development and lactation in women.

(3) Have Risperdal class action lawsuits been successfully brought on behalf of boys and men who have taken Risperdal?

Yes.  In 2012, Johnson & Johnson, the manufacturer of Risperdal, settled a group of cases brought by 130 lung men who had suffered abnormal breast enlargement after taking Risperdal.

(4) How can I learn whether I might be successful in a Risperdal lawsuit against Johnson & Johnson?

To potentially succeed in this type of lawsuit, it is important that you have actually been diagnosed with Gynecomastia.  If so, you are urged to immediately contact Audet & Partners, LLP for a free, completely confidential case evaluation.  You can do this either by calling (800) 965-1461, or by completing and submitting our confidential inquiry form on the right side of this page.

Join a class action. Call us: 800.965.1461